Evidence map›Paper›PMID 28464218›Full record

ArticleImmunology2017

Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype.

Natascha Köstlin, Margit Vogelmann, Bärbel Spring, Julian Schwarz, Judith Feucht, Christoph Härtel, Thorsten W Orlikowsky, Christian F Poets, Christian Gille

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 57 citations in OpenAlex.

  1. Observational
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Here, There, and Everywhere: Myeloid-Derived Suppressor Cells in Immunology.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Immunometabolism of Myeloid-Derived Suppressor Cells: Implications forInternational journal of molecular sciences · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Natascha KöstlinDepartment of Neonatology, Tübingen University Children's Hospital, Tübingen, Germany.ORCID 0000-0003-3718-5507
Margit VogelmannDepartment of Neonatology, Tübingen University Children's Hospital, Tübingen, Germany.
Bärbel SpringDepartment of Neonatology, Tübingen University Children's Hospital, Tübingen, Germany.
Julian SchwarzDepartment of Neonatology, Tübingen University Children's Hospital, Tübingen, Germany.
Judith FeuchtDepartment of Paediatrics I, Tübingen University Children's Hospital, Tübingen, Germany.
Christoph HärtelDepartment of Paediatrics, University Clinic Schleswig Holstein, Lübeck, Germany.
Thorsten W OrlikowskySection of Neonatology, Aachen University Children's Hospital, Aachen, Germany.
Christian F PoetsDepartment of Neonatology, Tübingen University Children's Hospital, Tübingen, Germany.
Christian GilleDepartment of Neonatology, Tübingen University Children's Hospital, Tübingen, Germany.
University Children's Hospital Tübingen · DEUniversitätsklinikum Aachen · DEUniversity Hospital Schleswig-Holstein · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections are a leading cause of perinatal morbidity and mortality. The outstandingly high susceptibility to infections early in life is mainly attributable to the compromised state of the neonatal immune system. One important difference to the adult immune system is a bias towards T helper type 2 (Th2) responses in newborns. However, mechanisms regulating neonatal T-cell responses are incompletely understood. Granulocytic myeloid-derived suppressor cells (GR-MDSC) are myeloid cells with a granulocytic phenotype that suppress various functions of other immune cells and accumulate under physiological conditions during pregnancy in maternal and fetal blood. Although it has been hypothesized that GR-MDSC accumulation during fetal life could be important for the maintenance of maternal-fetal tolerance, the influence of GR-MDSC on the immunological phenotype of neonates is still unclear. Here, we investigated the impact of GR-MDSC isolated from cord blood (CB-MDSC) on the polarization of Th cells. We demonstrate that CB-MDSC inhibit Th1 responses and induced Th2 responses and regulatory T (Treg) cells. Th1 inhibition was cell-contact dependent and occurred independent of other cell types, while Th2 induction was mediated independently of cell contact through expression of ArgI and reactive oxygen species by CB-MDSC and partially needed the presence of monocytes. Treg cell induction by CB-MDSC also occurred cell-contact independently but was partially mediated through inducible nitric oxide synthase. These results point towards a role of MDSC in regulating neonatal immune responses. Targeting MDSC function in neonates could be a therapeutic opportunity to improve neonatal host defence.

Indexed as

Cell PlasticityArginaseCell CommunicationCells, CulturedCoculture TechniquesFetal BloodGranulocytesHumansInfant, NewbornInflammationMyeloid-Derived Suppressor CellsNitric Oxide Synthase Type IIPhenotypeReactive Oxygen SpeciesSignal TransductionTh1 CellsARG1 protein, humanArginaseNitric Oxide Synthase Type IINOS2 protein, humanReactive Oxygen Speciesmyeloid-derived suppressor cellsneonateregulatory T cellsT helper cells

Identifiers

PMID28464218
PMCPMC5543463
OpenAlexW2611305033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.